It is a smart strategy to diversify your portfolio by investing in high-quality companies built on proven technologies.

According to Nova One Advisor, the global gene editing market size is calculated at USD 11.29 billion in 2025 and is expected ...

Azalea Therapeutics, Inc., a biotechnology company redefining precision genomic medicines in vivo, today announced its official launch and completion of $82 million in seed and Series A financing to ...

Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...

Global Talent Acquisition Pioneer Endorses Revolutionary Talent Intelligence Platform That Reduces Search Time From Days to ...

John L. Hennessy is President Emeritus of Stanford University as well as the James F. and Mary Lynn Gibbons Professor of ...

In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...

Caribou Biosciences shares rose after its CAR-T therapies showed high response rates and durable remissions in lymphoma and myeloma trials.

This growth is fueled by the escalating demand for biologics and biosimilars, continued innovation in cell line engineering, and increasing applications in gene therapy, monoclonal antibody production ...